Patent Assignment
Reel/Frame 025636/0221
Merger
Recorded: 2011-01-13
Pages: 6
Assignor
ADNEXUS THERAPEUTICS, INC.
Executed: 2007-10-19
Assignee
ADNEXUS, A BMS R&D COMPANY
RT. 206 & PROVINCE LINE ROAD, PRINCETON, NEW JERSEY, 08543-4000
Covered Property
(1)
Nucleic Acid Encoding 10FN3 Polypeptide Inhibitors of Type 2 Vascular Endothelial Growth Factor Receptors
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 13, 2011
From: CHEN, YAN; GETMANOVA, ELENA; WRIGHT, MARTIN C.; HARRIS, ALAN S.
To: ADNEXUS THERAPEUTICS, INC.
Reel/Frame 025636/0106 →
Change of Name
Jan 13, 2011
From: ADNEXUS, A BMS R&D COMPANY
To: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
Reel/Frame 025636/0395 →
Assignment of Assignor's Interest
Jan 13, 2011
From: ADNEXUS, A BRISTOL-MYERS SQUIBB R&D COMPANY
To: BRISTOL-MYERS SQUIBB COMPANY
Reel/Frame 025636/0406 →